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Abstract 
In this work a new phenomenological model of growth of cartilage tissue cultured in a rotating 
bioreactor is developed. It represents an advancement of a previously derived model of deposition 
of glycosaminoglycan (GAG) in engineered cartilage by (i) introduction of physiological 
mechanisms of proteoglycan accumulation in the extracellular matrix (ECM) as well as by 
correlating (ii) local cell densities and (iii) tissue growth to the ECM composition. In particular, 
previously established predictions and correlations of local oxygen concentrations and GAG 
synthesis rates are extended to distinguish cell secreted proteoglycan monomers free to diffuse in 
cell surroundings and outside from the engineered construct, from large aggrecan molecules, 
which are constrained within the ECM and practically immovable. The model includes kinetics of 
aggregation i.e. transformation of mobile GAG species into immobile aggregates as well as 
maintenance of the normal ECM composition after the physiological GAG concentration is 
reached by incorporation of a product inhibition term. The model also includes mechanisms of the 
temporal evolution of cell density distributions and tissue growth under in vitro conditions. After 
a short initial proliferation phase the total cell number in the construct remains constant, but the 
local cell distribution is levelled out by GAG accumulation and repulsion due to negative 
molecular charges. Furthermore, strong repulsive forces result in expansion of the local tissue 
elements observed macroscopically as tissue growth (i.e. construct enlargement). The model is 
validated by comparison with experimental data of (i) GAG  distribution and leakage, (ii) spatial-
temporal distributions of cells and (iii) tissue growth reported in previous works. Validation of the 
model predictive capability - against a selection of measured data that were not used to construct 
the model - suggests that the model successfully describes the interplay of several simultaneous 
processes carried out during  in vitro cartilage tissue regeneration and indicates that this approach 
could also be attractive for application in other tissue engineering systems. 
Key words: mathematical model, cartilage tissue engineering, tissue growth, glycosaminoglycan 
deposition, cell distribution 
 
Page 2 of 40
John Wiley & Sons
Biotechnology & Bioengineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 3 
INTRODUCTION 
Tissue engineering is one of the new strategies aiming to address the clinical problem of 
tissue and organ failure. One approach to tissue engineering is based on the integrated use of 
reparative cells, biodegradable scaffolds and bioreactor systems to cultivate functional tissue 
equivalents for potential clinical use (Vunjak-Novakovic and Goldstein, 2005), (Freshney et 
al., 2007). Scaffolds are designed to serve as a structural and logistic template for tissue 
development while the bioreactor should enable environmental control and support cell 
differentiation and functional assembly of components of extracellular matrix (ECM). Tissue 
engineering systems can also be used as relevant physiological models for controlled in vitro 
studies of cells and tissues under normal and pathological conditions. This approach is 
biomimetic in nature aiming to recapitulate processes during normal in vivo tissue 
development and promote regeneration of competent tissue equivalents capable of fully and 
functionally integrating with the host tissue upon implantation. Design of tissue engineering 
systems thus relies on knowledge and understanding of cell and tissue biology and 
physiology. In order to create the optimal cellular microenvironment in vitro, it is necessary to 
establish fundamental correlations between bioreactor cultivating conditions, cell response, 
and the resulting structural and functional properties of th  engineered tissue. Mathematical 
and computational modelling are indispensable tools in the analysis of such complex systems, 
generally applied to determine at least one of the following: (i) define in vitro cultivation 
conditions, (ii) characterize engineered tissues, and (iii) correlate cultivating conditions with 
the cell response and tissue properties (Obradovic et al., 2007).  
In this work we focus on the tissue engineering of cartilage, which is of considerable 
clinical importance. Over the past decade significant progress has been made in the 
cultivation of cartilaginous equivalents as well as in mathematical modelling of cartilage 
tissue engineering systems. A detailed review of different mathematical and computational 
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modelling strategies has recently been carried out (Sengers et al., 2007a,b). We highlight 
some of the contributions that are most relevant to the present work.  
A deterministic continuum model of the progression of chondrogenesis within cell-polymer 
constructs during cultivation was developed starting from first principles by (Obradovic et al., 
2000). In that model glycosaminoglycan (GAG) was chosen as a chondrogenesis marker since 
it is the major cartilage component together with collagen type II. The model accounted for 
consumption of oxygen, GAG synthesis as a function of the local oxygen concentration, and 
diffusion of both species, and was employed to calculate temporal and spatial patterns of 
GAG deposition. The predicted profiles of GAG concentration in engineered cartilage were 
quantitatively consistent with those measured via high-resolution (40µm) image processing of 
tissue samples (Martin et al., 1999). However, the model did not predict cell distributions nor 
the tissue growth and these parameters were determined experimentally and inserted as such 
in the model.  
Cell distribution over time in engineered cartilage was modelled based on population balances 
by (Pisu et al., 2004, 2006) but the authors did not take into account that the cells are 
anchored to ECM and move together with it. Cell migration, proliferation, differentiation and 
programmed death in porous scaffolds were successfully modelled using a multiphase 
approach (Lemon and King, 2007). This model is very useful for systems with motile cells, 
but cannot be directly applied to systems with anchorage-dependent and stationary cells. 
However, the model is solved in a moving formulation including coordinate transformation, 
which provides an elegant account of growth at a moving boundary. Viscoelastic models have 
also been  used to describe mechanical interaction between motile cells and their extracellular 
environment, assuming that all components - cells, scaffold, ECM – comprise a single phase 
moving at the same velocity.  
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In vitro cartilage tissue growth in rotating bioreactors has been addressed using a model based 
on the volume-of-fraction method predicting stimulation of ECM deposition on surfaces 
exposed to higher hydrodynamic shear stresses (Lappa, 2003). In addition, one of the recent 
models (Bilgen et al., 2009) also addressed stimulatory effects of the bioreactor 
hydrodynamic environment on  growth and properties of engineered cartilage.  
It can be seen that many relevant aspects have been tackled in considerable detail, but this 
brief review highlights the need, ultimately, for an integrated model of tissue development to 
assist process optimisation. This would need the ability to predict from first principles, the 
phenomena of diffusion and consumption of nutrients, GAG synthesis and deposition, cell 
distributions and tissue growth and be capable of including experimental data from a 
prototype process. This paper reports a phenomenological model of cartilage tissue culture in 
a rotating bioreactor and its calibration and validation by comparisons with observations of (i) 
GAG synthesis, aggregation and leakage, (ii) spatial-temporal distributions of GAG and cells, 
and (iii) tissue growth (i.e. construct enlargement) reported previously in (Vunjak-Novakovic 
et al., 1999) and (Obradovic et al., 2000).   
 
BRIEF DESCRIPTION OF THE EXPERIMENT  
As a model system, we have chosen cartilage tissue engineering in rotating bioreactors, which 
were shown to promote in vitro chondrogenesis by dynamic laminar flow and efficient mass 
transport to the cultivated tissue (Vunjak-Novakovic et al., 1999, 2002). The experiment has 
been described in detail previously (Obradovic et al., 2000). Here we summarize the main 
points that are important for our model. Initially, 5 million articular bovine calf chondrocytes 
were dynamically uniformly seeded onto biodegradable polyglycolic acid (PGA) scaffolds (5 
mm in diameter, 2 mm thick) for 3 days in mixed flasks. After this initial period the cell-
polymer constructs were transferred into rotating bioreactors and cultivated for 6 weeks in 
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total. In this experimental set-up it was shown that during the first four days the cells 
proliferate intensively, reaching approximately 11 million cells per scaffold. After this period, 
the cell number remains almost constant and the cell proliferation is negligible. It should be 
noted that chondrocytes are anchorage-dependent cells and shortly after seeding, surround 
themselves with ECM. For the first 10 days there is no growth of the constructs and matrix is 
deposited mainly in the outer zones of the scaffold indicating mass transfer limitations. Under 
the usual cultivation conditions, in a humidified incubator with 10% CO2, the oxygen 
concentration in the medium during culture is about 80 mmHg. After an initial 10-12 days, 
the cell-polymer constructs start to increase in size depositing ECM on the periphery and 
filling the inner construct spaces so that tissue generation proceeds from the construct 
periphery both outward and toward the construct centre (Freed et al., 1998). During this 
process, ECM accumulation (i.e. the increase of GAG concentration) causes local expansion 
of construct elements. Thus, in a small region of tissue, the cell density changes because even 
though the number of cells is constant the volume of the region increases with expansion. 
Over 6 weeks in culture, cell density decreases and becomes almost uniform throughout the 
engineered tissue (Obradovic et al., 2000). 
 
MATHEMATICAL MODEL   
In the rotating bioreactor, engineered constructs are relatively unconstrained to grow in any 
direction, experiencing only hydrodynamic shear stresses and low mechanical forces during 
tumbling and sliding about a stationary point within the bioreactor. However, our attempts to 
apply stress-strain models previously used for wound healing (Murray and Oster, 1984; 
Murray, 2003) and for compaction of cell populated gels (Moon and Tranquillo, 1993) were 
unsuccessful due to lack of knowledge of constitutive equations and material properties of the 
constructs. Thus, in this study we have focused on understanding the main mechanisms 
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responsible for the spatial distributions of nutrients, GAG and cells as well as for the construct 
growth.   
In order to simplify the problem and test implementation of various modeling assumptions for 
different processes involved in tissue accumulation and growth, we trace the time evolution of 
distributions of oxygen, GAG and cells in one space-dimension by approximating the 
construct as a rectangular cross-section of a cylinder (Figure 2). In this way, we can predict 
spatial distributions of key variables without the need for the extensive use of numerical 
techniques or computational resources necessary in multi-dimensional simulations. We 
assume symmetry and model component distributions over the half-height W/2 of the 
construct, which varies in time as a consequence of construct enlargement.   
 
Oxygen transport and consumption  
In this study we consider experimental conditions with an adequate supply of nutrients and a 
limiting role of oxygen. The local consumption rate is assumed to follow Michaelis-Menten 
kinetics, as used previously (Obradovic et al., 2000) leading to the differential equation 
predicting spatial and temporal changes in oxygen concentration (O) within the construct: 
          
OB
OCL
x
OD
dt
dO
o +
−
∂
∂
=
0
12
2
    (1) 
where 
oD  is the effective oxygen diffusivity, 1L  is the maximal O-consumption rate, C is the 
cell concentration, and 0B  is the value of  O at half-maximal O-consumption rate. Thus, it is 
assumed that the cellular O-consumption is insensitive to the rate of GAG synthesis and that 
the effective oxygen diffusion coefficient does not depend on the GAG concentration.  
 
GAG synthesis, deposition and transport 
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In several previous models of tissue growth, ECM has generally been regarded as a single 
material (Obradovic et al., 2000; Wilson et al., 2002; Pisu et al., 2004). In the present model 
we have adopted a more realistic approach (Klein and Sah, 2007) of a two-stage process of 
GAG accumulation: synthesis followed by aggregation. GAG degradation, considered as a 
separate process by  (Klein and Sah, 2007) is taken into account here within the production 
term as product inhibition. Thus, when the maximum GAG concentration Gmax is reached, 
corresponding to the physiological GAG concentration, it is held constant by continuous 
metabolism of the cells.  
Newly synthesized and secreted proteoglycan monomers are free to diffuse in the cell 
surrounding and through the scaffold. In this model these monomers are referred to “unbound 
GAG”. Hyaluronate and link proteins are also synthesized and secreted independently from 
the cells. These three major components then form proteoglycan aggregates in the ECM. 
Since proteoglycan aggregates are large, negatively charged molecules confined by collagen 
fibres, they are practically immovable and in this model are referred to “bound GAG”.   
Thus the model includes two separate equations tracing the temporal evolution of the 
spatial distributions of unbound and bound GAG. The concentration of unbound GAG UBG  is 
governed by an equation in a form previously described (Obradovic et al., 2000):  
 UBGAGGAG
UB
GAG
UB GcGtFOCk
x
G
D
dt
dG
12
2
),( −+
∂
∂
=   (2) 
where [ ]( ) [ ]max0 /1,0)(,01),( GGMAXAttMAXGtF nGAG −×−+= ∗ . 
 
The first term on the right hand side of the Eq. (2) represents the diffusive transport of the 
unbound GAG with diffusivity GAGD . The second term describes the rate of production of 
unbound GAG, which is proportional to the local oxygen and cell concentrations. The factor 
FGAG(t,G), as previously described (Obradovic et al., 2000), accounts for the fact that the 
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production is time-varying and product-inhibited. The experimentally observed time variation 
is captured by the factor [ ]nAttMAX )(,01 *0−+ , which describes a slow, constant GAG 
production rate between the 2nd and 12th days followed by a linear increase with time after *0t  
= 12 days.  Product-inhibition of unbound GAG production is included by means of the factor 
[ ])G/G(,MAX max−10  where G is the local concentration of bound GAG. If G > maxG  the 
effective production of unbound GAG ceases and cells maintain the bound GAG 
concentration in the tissue at the level 
maxG  by slow GAG turnover. The third term on the right 
hand side of the Eq. (2) represents the first-order kinetics of transformation of unbound to the 
bound GAG with the rate constant c1. 
The concentration G of bound GAG is described by the first order kinetics of unbound 
GAG aggregation as: 
UBGcdt
dG
1=                                   (3) 
  
Cell distribution  
After approximately 4 days of seeding and initial culture, cells in constructs reach their final 
numbers and cell proliferation ceases. Thus, after this period, the total number of cells in the 
construct is constant and hence the equation governing the distribution of cell density C must 
be: 
0=
dt
dC
                           (4) 
As mentioned before, temporal changes in local cell densities are determined by the 
local ECM accumulation. One of the consequences of this hypothesis is that the observed 
changes between initial and final spatial cell distributions must match the observed changes in 
the construct size. Preliminary calculations based on experimental results (Obradovic et al., 
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2000) indeed showed this correspondence. Since cell distributions and tissue construct size 
were independently measured, this modelling approach is further strengthened.  
 
Construct growth 
Our model deals only with one of the aspects of tissue growth – construct enlargement as a 
consequence of GAG accumulation – and does not distinguish some other possible 
stimulatory effects (e.g. hydrodynamic conditions) for tissue deposition and growth on 
construct surfaces.  We aimed to determine the local rates of construct deformation, assumed 
to be caused by the accumulation of deposited GAG. Initially, conversion of unbound to 
bound GAG will fill the spaces in an almost empty scaffold. However, as the bound GAG 
concentration increases, adjacent GAG chains will come into close proximity inducing mutual 
electrostatic repulsion due to the negative charge (Freed et al., 1998; Seog et al., 2005) 
causing the construct to expand. In this conceptual description of construct enlargement, 
regions of high initial cell concentrations will experience high local GAG synthesis rates and 
subsequent volume expansion.  Regions with lower cell concentrations, on the other hand, 
will experience lower GAG deposition and stretching. Consequently the cell distribution will 
tend to become more uniform with increasing time, as was actually observed experimentally 
(Obradovic et al., 2000). The simplest way to include this relation between GAG deposition 
and construct enlargement is to assume that increments in local strain due to construct 
expansion are proportional to increments of deposited GAG, provided that the local GAG 
concentration exceeds a certain minimum value Gmin.   
Expressed in terms of deformation we propose the following equation for expansion of tissue 
elements  





>
≤
=
−
==
min
min
1
0
GGifdGE
GGif
d
l
ll
l
l
γ     (5) 
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where γ is the local deformation of a construct element with original and deformed sizes l 
and l1 respectively, dG  is the deposited amount of bound GAG in a short time interval dt and 
is calculated using the Eq. (3). The new bound GAG and cell concentrations after the 
deformation are described by:  
)1/(),1/(
11
γγ +=+=
llll
GGCC                                               (6) 
In this way, the Eqs. (5) and (6) take into account increase of the construct size and 
changes of bound GAG and cell concentrations. It should also be noted that the total mass of 
the bound GAG and the total cell number in the stretched element are maintained constant 
during the stretch. 
 
Initial and boundary conditions  
During the seeding phase, cells are attaching to the scaffold, proliferating and starting to 
produce GAG. However, the exact mechanism of these processes is not known while cell 
distribution is significantly changing due to cell attachment and proliferation. Instead of 
guessing unknown cell number and distribution, we have simplified this seeding period by 
separating the phase of attachment and proliferation (1 day) during which the cells reach the 
number and density experimentally measured at day 4, and the GAG production phase, which 
starts at the end of day 1. With such initial conditions, the model predicts 0.5%ww GAG on 
day 3, which is in agreement with the experimental value of 0.7%ww (Vunjak-Novakovic et 
al., 1999) and serves as additional validation of our model. Summarising, the model starts 
( 0=t ) at the end of day 1, when the initial concentrations of bound and unbound GAG are 
zero throughout the construct, and cell distribution is equal to experimentally measured 
spatial distribution fC(x) of chondrocytes at day 4. Initially, a constant oxygen concentration 
within the constructs is assumed corresponding to that in the culture medium NO.  
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At subsequent times, symmetry at the construct centre is imposed by means of zero spatial 
gradient boundary conditions in all equations. At the construct surface, constant values of 
oxygen and GAG concentrations in the culture medium are assumed corresponding to those 
experimentally determined, i.e. NO and 0, respectively. In Table I, a summary of initial and 
boundary conditions is given. 
 
NUMERICAL SOLUTION PROCESS 
A two-stage process is used to evaluate changes in the construct over time. The initial 
construct half-height W/2 is subdivided into NX elements of equal sizes and initial 
distributions of oxygen, unbound and bound GAG, and cells are assigned to each element. 
The time period from day 2 to 41 is subdivided into NT equal time steps, each of duration ∆t. 
Equations (1)-(4) along with the ancillary Eqs. (5-6) for tissue growth, are solved through 
time as follows: 
• Stage 1: Diffusion Step. Using the size distribution of construct elements 
obtained at the end of the previous time step, Eqs. (1-4) are solved to yield new 
distributions of oxygen and unbound and bound GAG.  
• Stage 2: Stretch Step. The concentrations of oxygen, unbound and bound GAG 
are kept fixed inside each construct element and Eq. (5) is solved to compute 
the growth of each construct element, these sizes are then updated; 
distributions of cells and bound GAG are adjusted (Eq. (6)) to take account of 
growth keeping the mass of bound GAG and the cell number constant within 
each element. 
 
The Crank-Nicolson finite difference method (Chung, 2002) was used for Stage 1 to 
discretise Eqs. (1-3). The method applies local three-node parabolic interpolation functions to 
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evaluate derivatives on the non-uniform grids that arise after tissue growth commences. The 
well-known public-domain solver Lapack (http://www.netlib.org/lapack/double/dgbsv.f) was 
used to solve the resulting banded system of linear equations.   
At the start of Stage 2 the construct height will be subdivided into NX elements with 
the size ∆xi. According to Eq. (5) the length of the ith element will experience the following 
increase provided that the local bound GAG concentration satisfies Gi > Gmin at the end of the 
Stage 1:     
t
dt
dG
Exxx iiiNEWi ∆×××∆+∆=∆ ,      (7) 
where ∆xi,NEW is the new element size at the end of the time step ∆t  and E is the expansion 
coefficient. 
According to Eq. (6) the concentrations of bound GAG and cells are updated 
according to the following rules: 
)x/x(GG NEW,iiiNEW,i ∆∆=      (8a) 
)/(
,, NEWiiiNEWi xxCC ∆∆=      (8b)  
It should be noted that more accurate multi-step integration schemes could be applied, 
but the above numerical procedure is sufficiently accurate to demonstrate our conceptual 
model. 
Dependence of the results on the initial mesh spacing XNWx /12/ ×=∆  and the time 
step size ∆t was investigated by systematic variation of these parameters and inspecting 
variations in the unbound GAG leakage from the construct. The results were found to be 
mesh-independent around NX = 1,000 and NT = 10,000, corresponding to ∆x = 1 µm and ∆t = 
346s. 
 
Page 13 of 40
John Wiley & Sons
Biotechnology & Bioengineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 14 
PARAMETER ESTIMATION 
The system parameters were estimated from literature sources (Table II), but the experimental 
uncertainty of the values is rarely documented and may depend on process conditions in ways 
that are not accurately known. Values of four of these parameters, as well as two new 
parameters introduced in the present model, were obtained by fitting the numerical results to 
the experimental data.   
It should be noted here that experimental data on cell and GAG distributions measured 
in 2D histological cross-sections had to be normalized in the present model to 1D coordinates 
taking into account the constant total number of cells over the cultivation time. Thus, the 
experimental cell distribution on day 41 had to be multiplied by the ratio of the initial and 
final construct cross-sectional areas ( 62.1)/( 2 =startfinal dd ), where dstart = 5.5 mm and dfinal = 7 
mm, as determined experimentally (Obradovic et al., 2000).   
 
• Oxygen diffusivity DO  
In the present model, the oxygen diffusion coefficient in the growing constructs was assumed 
to be DO = 2.4×10-3 mm2/s corresponding to 80% of that reported for water. This is in 
agreement with the composition of native bovine calf cartilage, reported to contain about 80% 
of water, as well as with the composition of engineered cartilage constructs cultivated in 
rotating bioreactors for 6 weeks that contained about 90 % of water (Vunjak-Novakovic et al., 
1999).  
• Maximum bound GAG concentration Gmax  
The maximum GAG concentration in constructs was assumed to be approximately Gmax= 5.3 
%ww, which is in the range of values reported for bovine calf cartilage (Table II) and in 
agreement with the value (5.5 %ww) used in the previous model (Obradovic et al., 2000).  
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Unbound GAG diffusivity DGAG  
Diffusivity of unbound GAG, DGAG, was reported to lie in the range 10-7 - 10-6 mm2/s (Klein 
and Sah, 2007). In this work, we have assumed a value of 10-7 mm2/s and verified it by 
comparisons of the model predictions with experimentally measured rates of GAG leakage 
from the constructs, reported to be 1.90x10-6 g/l yielding approximately 30% GAG leakage of 
total GAG produced (Obradovic et al., 2000). 
 
Unbound GAG production rate constant kGAG 
The unbound GAG production rate constant kGAG was estimated from the best-fit of 
experimentally determined GAG profiles at day 10. This time is just prior to the onset of 
construct growth, which reduces the number of different mechanisms that influence GAG 
distribution. The minimum standard deviation between the model predictions and 
experimental data at 0t  = 10 days is found when kGAG = 2.38%ww/(day.mM.105cell/mm3) i.e.  
close to the value determined in (Obradovic et al., 2000).  
 
Construct growth parameters Gmin and E  
The maximum of experimentally measured GAG concentration in constructs on day 10 is 
around 4%ww. So, we expect that the value of Gmin, which determines the onset of the 
construct growth in Eq. (5) will be close to this value. The optimal values of Gmin and the 
expansion coefficient E must match the observed 1 mm increase of the construct height on 
day 41 and minimises discrepancies between the observed and predicted GAG distributions. 
The details are beyond the scope of this paper, but it should be noted that the final values of 
Gmin and E will depend on the exact target distributions chosen for optimisation. The values 
Gmin  = 4.1%ww and E = 17.17 were used in this paper model since it allowed predicted 
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construct height to match the measured value on day 41 and had low STD with the best 
qualitative agreement.  
To conclude this section we summarise the revised and additional estimates of system 
parameters in Table III and the targets used for their optimisation.  
 
RESULTS & DISCUSSION 
  Figure 3 shows the predicted spatial distributions of oxygen, cells, unbound and bound 
GAG for a selection of time points between the beginning and end of the experiment. The 
horizontal axis, coordinate x, indicates the distance along the construct height where the 
increase in the base width of the distributions indicates the enlargement of the construct. The 
predicted spatial distributions of oxygen decreases with depth due to uptake by the cells 
(Figure 3a), which is typical of a steady-state diffusion problem with a distributed sink. 
Decrease of oxygen concentration along the centreline with time is caused by the increase in 
construct size, increasing the distance for diffusion from the edge to the centreline.  The 
construct growth results in a general decrease of the cell concentration (Figure 3b) since the 
number of cells remains constant over the cultivation time. Cell density predicted by our 
model remains higher at construct surfaces than in the interior over the whole cultivation 
time. This is informed by our model’s prediction that, in spite of the initial high cell number 
in the external construct region, this region will not undergo significant volume expansion. 
This is, in turn, based on our observations which confirm that, whilst cells in the external 
construct region produce GAG, it leaks out of the construct without the opportunity to convert 
to bound GAG, and consequently the tissue elements are not stretched and cell density is not 
decreased. Distributions of unbound and bound GAG are consistent with these trends (Figures 
3c,d). On day 4 large peaks are predicted in distributions of both species near the construct 
edge where the initial cell density is the highest. In this region the bound GAG concentration 
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will first reach the threshold value Gmin in Eq. (5), determining the onset of local tissue 
expansion due to GAG deposition.    
The temporal behaviour of the unbound GAG concentration is predicted to peak early 
(around day 4). Between days 1 and 10 the bound GAG concentration also rapidly rises to 
about half its maximum value Gmax. Both distributions follow the general pattern of the cell 
density distribution at this stage suggesting a period of fairly unconstrained GAG production.  
After day 10 the product-inhibition effect built into the factor FGAG in Eq. (2) starts to 
dominate the unbound GAG production term. The unbound GAG concentration gradually 
decreases to about 15% of its peak value on day 41. As this process unfolds, the unbound 
GAG distribution becomes more uniform due to the combined effects of product-inhibition 
and diffusion. Without a diffusion or a sink term, the bound GAG distribution is dominated 
by local accumulation in response to the production due to the binding source term, so it 
continually increases. Construct growth provides a redistributing effect, which tends to 
smooth out the bound GAG distribution. Figure 3d clearly shows that the coupling between 
the unbound and bound GAG equations correctly regulates the bound GAG concentration 
towards a maximum of around 5.3%ww towards the end of the experiment.  Between 30 and 
41 days the interplay between product-inhibition and rapid changes in O-concentration, cell 
density and bound GAG concentration causes a complex distribution of unbound GAG with 
sharp peaks near the construct edge (Figure 3c).   
The unbound GAG concentration was observed to have the most complex dynamical 
behaviour.  Figure 4 compares the size of the space integrated values of the various terms in 
Eq. (2) to explore this in more detail. Except for a period of a few days after the start of the 
experiment, the space integrated unbound GAG concentration is dominated by the balance 
between the production and consumption terms. The imbalance between these two terms 
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generates some local accumulation immediately after the experiment has started, but most of 
the time diffusive transport will remove any excess production.   
Figure 5 shows spatial distributions of the ratio of diffusion and production term on 
selected days between 4 and 41, as well as the distributions of local production and diffusion.  
These diagrams confirm that both the diffusion and production terms exhibit strong peaks 
near the construct edge. The small positive peak in the diffusion-production ratio represents a 
quotient of small numbers, whereas the peak value of -1 at the outer edge shows that all 
unbound GAG that is locally produced is lost to leakage by diffusion.  Elsewhere the 
diagrams indicate that the unbound GAG is converted to bound GAG. Without a sufficient 
increase in the bound GAG concentration, the construct does not expand locally and the high 
initial cell density is maintained in this progressively narrower edge region as highlighted in 
the discussion of Figure 3(b).   
The model predicts an almost linear increase in the height of the construct and fits the 
available experimental data measured on days 10 and 41 (Figure 6). A constant average  
construct growth rate between days 10 and 41 was assumed in previous mathematical models 
of cartilage tissue engineering in rotating bioreactors (Obradovic et al., 2000; Lappa 2003), 
which successfully predicted changes in morphological appearance of the constructs over 
time (Lappa, 2003). The construct growth predicted by our model is in agreement with this 
assumption but still needs to be experimentally verified. 
Validation of the mathematical model is accomplished by comparison of the predicted 
distributions of cell densities on days 10 and 41, as well as of bound GAG on the 41st day of 
cultivation, with the experimental data (Figure 7).  The numerical results successfully predict 
the very sharp peak in the cell distribution near the construct edge and almost uniform cell 
density throughout the construct, confirming that the model captures the main features of 
construct growth with good accuracy. Model predictions and measured values of the bound 
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GAG concentration with experimental standard deviations from (Obradovic et al., 2000) are 
shown in Figure 7(b).  The distribution on day 10 is predicted within the experimental 
uncertainty, as expected, since this distribution was used to calibrate construct growth 
parameters Gmin and E.  On day 41 the bound GAG concentration near the centre of the 
construct is accurately predicted, but there are significant discrepancies between experimental 
and numerical results in the outer zone of the construct. The mathematical model appears to 
be lacking a mechanism to decrease the bound GAG concentration in this region. The 
inevitable appearance of a fluid boundary layer exterior to the construct suggests that the 
cause may be hydrodynamic in nature. There are several ways in which fluid flow might exert 
influence over the processes governing unbound GAG. These include hydrodynamic shear, 
which can cause cell dedifferentiation (Vunjak-Novakovic et al., 1996) and affect tissue 
growth (Lappa, 2003).  Also the precise values of Gmin and E are unknown and may vary 
throughout the construct and over time. There may also be an unknown mechanism of tissue 
growth on the construct surface such as the direct effect of hydrodynamic stimulation, as 
suggested by (Lappa, 2003). It may be possible to include an adjustment to overcome this 
limitation. However, since the exact biological or hydrodynamical cause is unknown, this 
would have to be a purely empirical correction based on the results of an experiment. Since 
we are interested in the underlying mechanisms, we leave this as an item for future 
experimental and theoretical investigation.   
The general agreement between experimental data and numerical predictions suggests that 
our model successfully incorporates most of the biological processes that are currently known 
to affect regeneration of engineered cartilage tissue. However, the description of these 
processes has been greatly simplified. Subject to availability of values of relevant system 
parameters it would be fairly straightforward to expand the model to include a more 
sophisticated account of the nutrient environment, including separate transport equations for 
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additional nutrient species.  The production and outward diffusion of metabolic waste 
products can be described by further species equations making it possible to resolve 
environmental conditions such as pH. Moreover, the model could be expanded to account for 
production and accumulation of cell secreted stimulating growth factors, but additional 
experimental data is needed to determine the exact roles of these factors and influences on 
GAG production rates over the cultivation time.  
In addition, the model could be further developed to incorporate collagen synthesis and 
accumulation when appropriate experimental data becomes available. With collagen 
incorporation, GAG – collagen interactions can be defined and used to describe unbound to 
bound GAG turnover in a more realistic manner. Also incorporation of collagen will limit 
stretching of the tissue elements and consequent construct growth. 
It is also possible that our model could be linked to models predicting biomechanical 
properties of cartilaginous tissues (e.g. Vunjak-Novakovic et al., 1999, Williamson et al., 
2001; Hasler et al., 1999) and used to distinguish the effects of bound and unbound GAG. 
For example, it would be interesting to apply the model to cartilage tissue engineering 
systems employing physical stimulation (Hu and Athanasiou, 2006; Mauck et al., 2000) if the 
data on local GAG concentrations and GAG release are available. However, special attention 
is needed to account for mechanical stimulation, which according to (Mauck et al., 2003) 
could cause changes in the rate of unbound GAG production as well as in the transport rates 
of GAG, nutrients and metabolic products. 
It should also be noted that the values of system parameters should be more accurately  
determined. The numerical results were found to be quite sensitive to oxygen and unbound 
GAG diffusivity. Moreover, the dependence of these diffusivities on local conditions was 
recognised, but not explicitly included in the present model. Further experimental work to 
quantify these parameters as well as unbound GAG production rate and unbound-bound GAG 
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binding rate more accurately would clearly be beneficial. In the meantime, the effect of lack 
of knowledge on the model outcomes can be explored by means of the type of sensitivity 
analysis that was used for the estimation of uncertain system parameters.   
In spite of the reservations noted above, our mathematical model has successfully 
integrated all known biological and transport mechanisms processes that govern regeneration 
of engineered cartilage tissue in a rotating bioreactor with a simple, but effective, account of 
the interplay between GAG production and deposition, cell density distribution and construct 
enlargement.  It is the first model proposed to include mechanisms of GAG accumulation and 
tissue enlargement offering an approach attractive to be extended to other tissues and tissue 
engineering systems.  
 
CONCLUDING REMARKS 
We have proposed a conceptually simple phenomenological model of GAG deposition and 
growth of an engineered tissue construct cultured in a rotating bioreactor.  Models of tissue 
growth generally regard the extracellular matrix as a single substance.  Our model recognises 
that proteoglycans are initially produced by cells in a mobile form, which we have termed 
“unbound GAG”, part of which is slowly converted within the ECM into immobile aggregates 
termed “bound GAG”.  This more realistic account of the production process has allowed us 
to account for the experimentally-observed substantial rates of leakage of GAG from the edge 
of tissue construct.  Furthermore, the model recognises the anchorage-dependent nature of 
chondrocytes in cartilaginous tissues.  During the main cultivation phase and ECM 
regeneration, the total number of cells in the construct is constant, but their local distribution 
is controlled by local stretching  of tissue elements, which in turn is governed by local rates of 
GAG deposition.  The model lends itself well as a test bed for different growth rules.  The 
agreement between the predicted trends of cell distribution and construct enlargement with 
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measurements confirms the validity of this simple connection between GAG deposition, cell 
distribution and tissue deformation in cases without significant mechanical stimulation of 
tissue growth.    
We must acknowledge a remaining weakness of our model, which is the relatively 
poor agreement of predicted and measured profiles of GAG concentration in the surface layer 
of ~200 µm of the construct.  It is likely that this is attributable to (i) the effects of 
hydrodynamic shear at tissue surfaces, which can affect cell dedifferentiation (Vunjak-
Novakovic et al., 1996) and tissue growth (Lappa, 2003), (ii) unknown value of Gmin and 
exact value of repulsion E, which may differ throughout the construct and over time, and/or 
(iii) possibly other mechanisms of tissue growth on the surface such as direct effect of 
hydrodynamic stimulation, as suggested by (Lappa, 2003).  These effects clearly require 
future study. 
Nevertheless, our model has captured the major phenomena and kinetics controlling 
the spatial and temporal characteristics of cartilage tissue in a rotating bioreactor.  It can be 
readily extended 2D or 3D and the validation of its predictive capability - against a selection 
of measured data that were not used to construct the model - suggests that it may be a useful 
starting point for the development of procedures for the optimisation of tissue growth 
environment.  
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Table I: Summary of initial conditions and boundary conditions 
Boundary conditions Equation. Variable Initial condition 
at t = 0 (1st day) 
centreline (x = 0) construct edge (x = W/2) 
(1) O 0)0,( NtxO ==  0/ =∂∂ xO  0),( NtWxO ==  
(2) GUB 0)0,( ==txGUB  0/ =∂∂ xGUB  0=UBG  
(3) G 0)0,( ==txG  - - 
(4) C )()0,( xftxC C==  - - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table II: System parameters 
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Symbol Parameter Value 
 
Source 
L  half of the scaffold 
thickness 
1 mm (Obradovic et al., 2000) 
d  scaffold diameter 5 mm (Obradovic et al., 2000) 
• NC number of cells in the 
construct   
1.1×107 cells (Obradovic et al., 2000) 
NO oxygen concentration in 
the culture medium 
0.125  mM  (Obradovic et al., 2000) 
†
 DO oxygen diffusivity 1.5×10-3 mm2s-1 (Obradovic et al., 2000; 
Himmelblau, 1964) 
L1 maximum oxygen 
consumption rate 
1.86×10-13  mol.(105cell)-1.s-1 (Obradovic et al., 2000) 
BO oxygen concentration at 
half-maximal 
consumption rate 
 6×10-3 mM  (Obradovic et al., 2000) 
(Haselgrove et al., 
1993) 
† DGAG 
 
unbound GAG diffusivity Range  10-7 - 10-6mm2s-1 (Klein and Sah, 2007) 
† kGAG 
 
unbound GAG 
production rate  
2.3%ww/(day.mM. 
105cell/mm3) 
(Obradovic et al., 2000) 
0t
 start time of  construct 
growth  
10 day (Obradovic et al., 2000) 
∗
0t  start time of accelerated 
GAG production 
12 day (Obradovic et al., 2000) 
An accelerated GAG 0.11 day-1 (Obradovic et al., 2000) 
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production rate constant 
† Gmax 
 
maximum bound GAG 
concentration 
Range 5.0-6.0  %ww (Obradovic et al., 2000) 
c1 GAG binding rate  1.2×10-5 s-1 (Klein and Sah, 2007)  
• Experimental data in (Obradovic et al., 2000) showed ±20% variations of the cell count on 
day 4, 10 and 41.  These were attributed to the measurement technique and a constant cell 
count was assumed to obviate the need to include a population balance. 
†
  Firm or revised estimate of the parameter is developed in section Parameter Estimation 
 
 
TABLE III: Summary of revised and additional system parameter estimates 
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Symbol Parameter Value Measured quantity used for 
parameter selection 
DO oxygen diffusivity 2.4×10-3 mm2s-1 80% of diffusivity of oxygen in pure 
water & checks of distributions of O 
and GAG 
DGAG 
 
unbound GAG 
diffusivity 
10-7 mm2s-1 GAG leakage rate 
kGAG 
 
unbound GAG 
production rate  
2.38%ww/(day.mM. 
105cell/mm3) 
GAG distribution at start of 
construct growth ( 0t  = 10 days) 
Gmax 
 
maximum bound 
GAG concentration 
5.3 %ww 1D normalisation of 3D data in 
(Obradovic et al., 2000) 
Gmin 
 
minimum bound 
GAG concentration  
4.1 %ww GAG concentration just before start 
of construct growth ( 0t  = 10 days) 
E construct expansion 
coefficient  
17.17 construct size at *t  = 41 days 
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Figure captions: 
Figure 1. Cartilage tissue engineering model system. a) Bovine articular cartilage, safranin O 
stain, x20 original magnification. Columnar arrangement of chondrocytes in lacunae 
surrounded by abundant ECM. b) Chondrocytes attached on PGA fibres after 3 days of 
seeding (SEM, scale bar: 10 µm) (with permission from (Vunjak-Novakovic et al., 1998)). c) 
Rotating bioreactor: cell-polymer constructs are suspended in medium flow, settling at a 
stationary point in tumble-slide regime. d, e, f) Progression of chondrogenesis in cell-polymer 
constructs cultivated in rotating bioreactors after: d) 5 days, e) 10 days, f) 41 days. Safranin O 
stain (adapted with permission from (Obradovic et al., 2000)). 
 
Figure 2. Real 3D construct is approximated with a 1D rectangular cross-section  of the 
cylinder. W=2mm is the initial height of the cylinder, which after 41 days increases to 
W=3mm; x axis represents the distance along the construct height, in-between x=±W/2.   
 
Figure 3. Predicted spatial distributions of (a) oxygen, (b) cells, (c) unbound GAG and (d) 
bound GAG at selected times between day 1 and 41. (Unbound and bound GAG distributions 
on day 1 are zero).    
 
Figure 4. Temporal behaviour of space integrated values of terms in Eq. (2): ∫
−
2/
2/
W
W
UB dx
dt
dG
 -
transient, ∫
− ∂
∂2/
2/
2
2W
W
UB
GAG dx
x
GD - diffusion, ∫
−
2/
2/
W
W
GAGGAG dxFOCk - production  and ∫
−
2/
2/
1
W
W
UBdxGc - 
consumption.   
 
Figure 5. Spatial distributions of (a) ratio of diffusion / production, (b) production and (c) 
diffusion of unbound GAG.  
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Figure 6. Comparison of measured (exp.) and modelled (mod.) increase of the height of the 
construct.    
 
Figure 7. Comparison of measured and predicted spatial distributions of (a) cells and (b) 
bound GAG on days 10 and 41. Experimental GAG concentration profiles (symbols) 
measured by image processing of construct sections (average ±SD, n=2-4) are taken from 
(Obradovic et al., 2000). 
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Figure. 1  
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Figure. 2  
241x222mm (300 x 300 DPI)  
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Figure. 3  
219x261mm (300 x 300 DPI)  
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Figure. 4  
142x165mm (300 x 300 DPI)  
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Figure. 5  
317x198mm (300 x 300 DPI)  
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Figure. 6  
143x215mm (300 x 300 DPI)  
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Figure. 7  
258x160mm (300 x 300 DPI)  
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